Physician-led metabolic optimization built around your history, goals, laboratory findings, contraindications, preferences, and response to treatment.
Metabolic Optimization is designed for patients who value continuity, transparent decision-making, and treatment adjusted to their clinical response.
You’ve run the numbers. A1C is creeping up. Energy isn’t what it was. You want a physician who reviews your laboratory results and builds the treatment plan around your clinical picture.
You want a physician to follow your response over time, review relevant laboratory results, and make medication decisions in the context of your full treatment plan.
Route of administration matters, but it is only one part of medication selection. Your treating physician reviews FDA-approved oral and injectable options, expected benefits, risks, coverage, availability, and your individual clinical needs before recommending a treatment.
Physician fee. Pharmacy cost. Labs. Three separate line items. Metabolic medications are billed by the pharmacy direct — Medication cost is separate from the physician fee. You see exactly what you pay for clinical oversight versus medication.
Metabolic therapy requires clinical judgment — dose selection, side-effect management, lab-driven titration, accounting for kidney function, thyroid status, existing medications, and the specific patterns of your biology. Those decisions require individualized clinical judgment and ongoing follow-up.
Every Empower Med protocol starts with the labs that actually matter for metabolic optimization — HbA1c, Basic Metabolic Panel, Lipid Panel, CBC. The results help your treating physician determine which medication format fits your case, which starting dose, and how to titrate over time. If your A1C moves faster or slower than expected, the protocol adjusts. If side effects appear, dosing changes. The protocol follows your biology, not a template.
“Metabolic treatment, nutrition, activity, and clinically appropriate hormone care can be coordinated as parts of one treatment plan.”
When TRT is independently clinically indicated, metabolic and hormone care can be coordinated through physician oversight so changes in one treatment plan can be considered alongside the other.
FDA-approved medications are considered when clinically appropriate. A compounded medication is not treated as a routine substitute for an FDA-approved product and is considered only when an individualized patient need and applicable law support its use.
FDA approved in April 2026 for chronic weight management in eligible adults with obesity or overweight plus at least one weight-related condition, together with reduced-calorie diet and increased physical activity. It is a once-daily oral GLP-1 medication. Whether it is appropriate depends on the patient’s clinical picture, contraindications, coverage, and preferences.
FDA-approved tirzepatide products are available for specific indications. Medication selection and dosing are individualized, and prescribing follows the approved product labeling and the patient’s clinical circumstances.
FDA-approved semaglutide products are available for specific indications. Route, dose, contraindications, monitoring, insurance coverage, and patient preference all factor into whether semaglutide is the right choice.
Compounded preparations are not commercially manufactured drug products. They are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing. Compounding may be considered only when it serves an individualized clinical need and all applicable prescribing and pharmacy requirements are met. Availability can change with federal law, shortage status, and pharmacy capability.
Metabolic therapy done responsibly requires a baseline panel and ongoing monitoring. Your treating physician orders the labs that actually inform a metabolic protocol — no upcharged “advanced” panels that don’t change the plan.
Labs are ordered through Empower Med and billed at the published patient prices. Laboratory charges remain itemized and are never buried inside a physician fee.
Physician fee. Labs. Medication. Three separate line items. You see all of them.
Here’s the full breakdown at Empower Med:
| Physician care feeInitial evaluation, history review, protocol design, medication selection, dose titration, and ongoing physician-directed follow-up. | $125/ month |
| Baseline lab panel HbA1c, BMP, Lipid Panel, CBC. Billed at the published patient price and itemized separately. | $59one-time |
| Medication Medication cost varies by the product selected, dispensing pharmacy, insurance coverage, dose, and whether an FDA-approved or lawfully compounded medication is clinically appropriate. Any pharmacy charge is itemized separately from the physician fee. | Variesby medication |
Your physician fee is transparent and fixed by the care schedule above. Medication cost is separate and depends on the medication actually prescribed.
FDA-approved products may be covered by insurance or available through manufacturer or pharmacy programs; cash pricing varies. Compounded medication, when clinically appropriate and lawful, is priced by the dispensing pharmacy and is not represented as equivalent to an FDA-approved product. Empower Med does not choose a medication solely because it is cheaper.
Patients who previously purchased an Open-Access Lab panel and now enroll in Metabolic Optimization receive a $100 credit against their first month’s physician fee. The lab purchase serves as your clinical entry point — prior investment in understanding your biology, credited directly toward treatment. Net physician fee for your first month: $25.
“The protocol follows your biology, not a template.”
Individualized care, ongoing monitoring, and treatment decisions built around your case.
Request a ConsultationOr reach out directly — info@empowermed.us · (571) 293-6244
